Skip to main content

Want a detailed portfolio tracker?

Geovax Labs (GOVX) P/E (2020 - 2026)

Geovax Labs (GOVX) P/E from Sep 30, 2020 to Jul 20, 2026. The TTM Geovax Labs (GOVX) P/E is -0.05. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Geovax Labs (GOVX)

YearP/EChange
2026-0.05-67.05%
2025-0.16-56.64%
2024-0.38-84.70%
2023-2.48-42.72%
2022-4.33-82.59%
2021-24.87-81.26%
2020-132.71N/A

Comparison Geovax Labs (GOVX) P/E with competitors

Geovax Labs (GOVX) P/E is -0.05.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-103.14%
NBYStablecoin Development Corp0.00-107.93%
ENLVEnlivex Ltd0.07-237.96%
FGENFibroGen Inc0.24-542.71%
CHRSCoherus Biosciences Inc0.85-1664.96%
FBIOFortress Biotech Inc0.95-1850.32%
ORMPOramed Pharmaceuticals Inc1.50-2872.11%
AGENAgenus Inc3.01-5650.68%
INVAInnoviva Inc3.15-5917.01%
VXRTVaxart Inc3.55-6646.83%
CRMDCorMedix Inc3.63-6791.99%
CVACCureVac N.V.4.45-8299.22%
GLPGGalapagos NV4.86-9061.32%
SRPTSarepta Therapeutics Inc4.88-9104.11%
ABEOAbeona Therapeutics Inc5.39-10036.26%
ABUSArbutus Biopharma Corp5.60-10420.08%
ZVRAZevra Therapeutics Inc5.89-10957.90%
SPROSpero Therapeutics Inc6.23-11587.21%
CGENCompugen Ltd6.31-11744.90%
RIGLRigel Pharmaceuticals6.87-12774.25%
SLXNSilexion Therapeutics Corp7.30-13556.27%
OMEROmeros Corporation9.26-17176.06%
AUPHAurinia Pharmaceuticals Inc9.58-17777.70%
PLXProtalix BioTherapeutics Inc10.89-20186.47%
ACADAcadia Pharmaceuticals Inc11.73-21731.14%
TBPHTheravance Biopharma Inc12.26-22715.31%
ADMAAdma Biologics Inc12.42-23003.03%
HRMYHarmony Biosciences Holdings Inc13.82-25588.86%
SABSSAB Biotherapeutics Inc14.14-26171.69%
NAGENiagen Bioscience Inc14.82-27429.38%
INCYIncyte Corp15.82-29281.88%
REGNRegeneron Pharmaceuticals Inc15.86-29344.77%
PBYIPuma Biotechnology Inc17.32-32035.73%
CPRXCatalyst Pharmaceuticals Inc17.44-32263.70%
EXELExelixis Inc17.54-32445.74%
TGTXTG Therapeutics Inc18.97-35079.52%
MDXGMimedx Group Inc20.55-38005.45%
XOMAXOMA Royalty Corp22.87-42289.41%
ARGXArgen X SE24.30-44914.52%
CTMXCytomX Therapeutics Inc24.82-45879.32%
XOMAOXOMA Royalty Corp25.34-46845.23%
HALOHalozyme Therapeutics Inc25.62-47359.63%
XOMAPXOMA Royalty Corp25.67-47445.21%
VRTXVertex Pharmaceuticals Inc27.99-51732.67%
RPRXRoyalty Pharma plc - Class A28.69-53010.46%
SLNOSoleno Therapeutics Inc29.02-53615.05%
ASNDAscendis Pharma A/S30.09-55588.91%
LGNDLigand Pharmaceuticals Inc - Class B37.91-70023.81%
APLSApellis Pharmaceuticals Inc39.02-72069.61%
BMRNBiomarin Pharmaceutical Inc42.21-77954.30%
KRYSKrystal Biotech Inc45.34-83730.18%
ONCBeiGene Ltd69.54-128358.43%
PHARPharming Group N.V.75.03-138475.07%
TECHBio-Techne Corp101.96-188149.18%
VCELVericel Corp109.92-202835.84%
ALNYAlnylam Pharmaceuticals Inc117.96-217671.53%
GMABGenmab140.29-258848.37%
TLXTelix Pharmaceuticals Ltd162.15-299170.16%
CORTCorcept Therapeutics Inc212.86-392688.47%